Marc Beer

Marc Beer has extensive experience in the medical industry. Marc has held Chairman roles at BioTE Medical (2021), Papyrus Therapeutics Inc. (2021), Origami Surgical (2020), and Minerva Neurosciences (2013). Marc was also Co-Founder and Chairman of LumeNXT LLC (2018), Co-Founder, Former Chairman and CEO, and Current Strategic Advisor at Renovia Inc. (2016), Chairman of Good Start Genetics (2010), Chairman of Myolex (Skulpt) (2015), Chief Executive Officer at Aegerion Pharmaceuticals (2010), and Chief Executive Officer at ViaCell (2000).

Marc Beer attended Miami University from 1983 to 1987, where they earned a Bachelor of Science degree.